We have found a defect in the ouabain-sensitive Na+,K+-ATPase (Na+ pump, EC 3.6.1.37) oferythrocytes from streptozotocin diabetic rats. This defect was accompanied by an increase in cell volume and osmotic fragility and a decrease in the cytosolic K+/Na+ ratio. There was also a doubling in the time needed for diabetic erythrocytes to pass through 4.7-jim channels in a polycarbonate filter. Our data are consistent with a primary defect in the erythrocyte Na+ pump and secondary changes in cell volume, osmotic fragility, K+/Na+ ratio, and cell ifiterability. All were reversed or prevented in vivo by insulin or the aldose reductase inhibitor Sorbinil. Protein kinase C agonists (phorbol ester and diacylglycerol) and agonist precursor (myoinositol) reversed the Na+ pump lesion, suggesting that protein kinase C-dependent phosphorylation of the 100-kDa subunit regulates Na+ pump activity and that insulin can influence erythrocyte protein kinase C activity. Ouabain inhibition of the erythrocyte Na+ pump also produced increases in cell size and reductions in rates of ifitration. Theoretical treatment of the volume changes also predicts reduction in ifiterability as a consequence of cell swelling. We suggest that enlarged erythrocytes could play a role in the evolution of the microvascular changes of diabetes mellitus.
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A decrease in ouabain-sensitive Na',K+-ATPase (Na' pump, EC 3.6.1.37) activity has been found in diabetic lens, nerve, and glomerulus (1) (2) (3) . This Na' pump impairment was corrected by aldose reductase inhibitors or by normalization of blood sugar with insulin. In contrast, Na' pump activity in diabetic erythrocytes (RBCs) is a subject of controversy, with reports of increases (4, 5) and decreases (6, 7) . We therefore initiated a study of the Na' pump in erythrocytes of rats rendered diabetic with streptozotocin. The streptozotocin diabetic rat provided a reliable source ofRBCs whose time-integrated exposure to hyperglycemia was determined by measurement of glycated albumin. Since nondiabetic RBCs must deform considerably to pass through small capillaries, we were especially interested in learning whether such a putative Na' pump lesion would influence the volume and hence filterability of Na' Pump Activity. Na' pump ATPase activity was measured in RBC membrane fragments by the method of Reinila et al. (9) . [y-32P]ATP (1000-3000 Ci/mmol; 1 Ci = 37 GBq) was purchased from New England Nuclear. Nucleotides were separated from 32P1 with Norit (11) . ATP concentrations much above 1 mM could not be used, since we found a 37% inhibition ofactivity at 3 mM ATP and virtually complete inhibition at 7.5 mM ATP when the concentration of free Mg2' was 5 mM.
Such substrate inhibition has been previously reported in the Na' transport system (9) . In the case of ATP, Vm. was determined from data in the linear portion of the LineweaverBurk plot, prior to the onset of substrate inhibition. Na' pump activity in intact cells was measured as 86Rb transport, activity was measured with 86Rb as described above. The protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) was purchased from Sigma.
RBC 
RESULTS
ATP and Sorbitol Measurements. Rat RBC ATP levels were 2.26 ± 0.09 mM (n = 3), as reported by Lehninger (17) . In diabetic RBCs, ATP levels were 1.64 ± 0.03 mM (n = 3). Reduced levels ofATP were not found in RBCs ofdiabetic rats treated with insulin for 10 days or in RBCs of insulin-treated diabetic humans (18) . Cytoplasmic sorbitol levels were 10 p.M in nondiabetic RBCs and 50-60,uM in diabetic RBCs.
Activity of the Ouabain-Sensitive Na+,K+-ATPase. Na+ pump activity in RBC membrane fragments from untreated diabetic rats was reduced 30-50o. The size of the Na+ pump defect correlated with the severity of diabetes (r = 0.83; n = 14) determined by levels of (nonenzymatically) glycated plasma albumin (Fig. 1, 0) . The normal ouabain-insensitive ATPase activity (6 Effects of Insulin and Sorbinil on the Development of the Na+,K+-ATPase Defect. Na+ pump impairment (measured in RBC ghosts) reached a maximum by day 10 after the onset of streptozotocin diabetes (Fig. 2, 0) . Insulin treatment prevented Na+ pump impairment when begun at the time of streptozotocin injection and reversed the established defect after 8 days. The Na+ pump defect was prevented when Sorbinil was given from the time of streptozotocin injection.
Kinetic Parameters for the Na+ Pump and Cytoplasmic Na' and K+ Measurements. We measured Km for ATP, Na+, and K+ in nondiabetic and diabetic RBCs (Table 1) . While there were minimal changes in the Km for Na+ and K+, the Km for ATP in diabetic cells was doubled. The Vma, was unaltered for the diabetic Na+ pump. The mol ratios of cytosolic K+ to Na+ were 19.2 ± 2.6 (n = 8) for nondiabetic RBCs and 15.1 ± 3.4 (n = 8) for diabetic RBCs (P < 0.02). The corresponding packed cell volumes were 64.0 ± 2.8 ,um3 for nQndiabetic cells and 79.6 ± 2.7 pum3 for diabetic cells. These data reflect Na+ pump impairment in diabetic RBCs and suggest that the observed water accumulation is secondary to increases in cytoplasmic Na+. There was an inverse correlation between the K+/Na+ ratio and RBC volume (r = -0.55, n = 16, P < 0.05).
Osmotic Fragility. Fifty percent of diabetic RBCs underwent lysis at 165 mosmol/kg (Fig. 3) . RBCs from nondiabetic rats exhibited a comparable degree of lysis at 120 mosmol/kg. At 165 mosmol/kg, the extent of hemolysis was 3-fold greater in diabetic cells. The time course for development of increased osmotic fragility resembled that for development of the Na+ pump defect (Fig. 2, o) . The degree of increased osmotic fragility was related to the magnitude of Na+ pump impairment (Fig. 2) . Prevention of Na+ pump impairment by Sorbinil treatment also prevented increased osmotic fragility.
Volume Changes. Na' pump impairment in diabetic RBCs was associated with an 11-29% increase in packed cell volume (Fig. 1, o) The degree of cell swelling correlated with the prolongation of filtration times (Fig. 4 , r = 0.96, n = 19).
Mimicking Effects of Diabetes on RBC Na+ Pump Activity, Cell Volume, Fragility, and Filterability with Ouabain. We used ouabain to inhibit the Na' pump and to compare changes in volume to those in filterability. At 500 A&M, ouabain produced virtually complete inhibition of Na' pump activity. At 100 ,uM, ouabain caused 50o inhibition, which is often encountered in the chemically diabetic rat. The induction of a Na' pump defect with ouabain also produced increases in osmotic fragility (data not shown). The correlation between cell swelling and reduced filterability was the same whether Na' pump impairment was caused by hyperglycemia or ouabain (Fig. 4) .
We did not correlate Na+ pump impairment in the ouabainexposed RBCs with the degree of swelling because ouabain inhibition occurs rapidly (<1 min), whereas cell swelling evolves slowly over a period of hours owing to slow rates of Na' influx (19 (20) , we evaluated its effects on the diabetic RBC. myo-Inositol corrected Na' pump impairment in this cell over 95% in 2 hr (Table 2) . myo-Inositol is a precursor of inositolphospholipids, which are hydrolyzed to yield the protein kinase C activator diacylglycerol. We evaluated protein kinase C involvement by testing the effects of a phorbol ester and diacylglycerol, both of which also corrected the Na' pump defect (Table 2) . Incubation with insulin also produced effective Na' pump correction in vitro. H7, a selective inhibitor of protein kinase C (21), could block Na' pump correction by diacylglycerol, phorbol ester, and insulin ( Table 2) . Amounts of diacylglycerol that reverse Na+ pump impairment markedly stimulated the incorporation of phosphate into its 100-kDa a-subunit, which contains both the ATP and the ouabain binding sites. Incubation of RBC ghosts with alkaline phosphatase markedly reduced Na' pump activity (data not shown). Greene and Lattimer (22) have reported in vitro normalization of the impaired Na+ pump in diabetic sciatic nerve with protein kinase C agonists, and agonist responsive protein kinase C activity has been described in mammalian RBCs (23) .
DISCUSSION
Our data suggest that impairment of RBC Na' pump activity and the accompanying cell swelling merit attention as puta- (24) . We found reversal of the effect by insulin in vitro after 60 min (Table 2) .
We We have presented biochemical data that implicate protein kinase C and provide a context for understanding Nat pump impairment in the diabetic RBC and its correction in vitro by some agonists. It is noteworthy that correction of the Nat pump with insulin is prevented by a selective inhibitor of protein kinase C (21) . These data, however, do not provide a link between the polyol pathway and the impaired Na+ pump.
In our diabetic animal model, hyperglycemia reaches maximal levels between days 3 and 4 following streptozotocin injection (8) . Thus, hyperglycemia is well established for more than 5 days before maximal Nat pump impairment is observed. On the other hand, once established, the level of Na+ pump impairment correlates well with levels of glycated plasma albumin (Fig. 1) . These findings do not exclude the important possibility that insulinoprivia (as distinct from hyperglycemia) contributes to the observed Na+ pump impairment. Moreover, it has been observed that insulin can activate some phospholipases and thereby increase levels of diacylglycerol in fibroblasts and myocytes (26, 27) . This effect of insulin may result from a GTP-binding-proteindependent activation of phospholipase C (26) and is in harmony with the data that implicate protein kinase C in the regulation of the Na+ pump (Table 2) .
Modest levels of sorbitol are found in diabetic RBCs (50-100 ,uM) in contrast to the levels (8-30 mM) found in other diabetic tissues, such as lens, glomerulus, and nerve (1-3) . Thus, sorbitol-associated increases in osmolality cannot account for the observed increases in volume. More likely the increase in volume is due to the decreased rate of Nat extrusion. The observation that this Na+ pump impairment is prevented as well as reversed by Sorbinil suggests one or more loci of convergence between the polyol pathway and regulation of the Na+ pump (28, 29) .
We have documented three immediate adverse consequences of Na+ pump impairment: an increase in RBC volume and a consequent increase in osmotic fragility and decrease in filterability. In correlation with our ouabain experiments, all of these changes were reversed when the Nat pump was normalized with Sorbinil or insulin. Because of Nat pump impairment, already swollen diabetic RBCs are less able to contend with further swelling, since they are closer to the bursting point. This is in keeping with the concept that membrane area is a limiting parameter in the capacity of RBCs to adapt to changes in shape and volume (30) .
The data in Fig. 4 show that a 22% increase in cell volume produces a doubling in the filtration time for RBCs. In attempting to understand these data, three connected theoretical questions occur. (i) What can account for the very large amplification factor between cell volume and filterability? (ii) Is it reasonable to expect similar amplification of volume changes in vivo? (iii) Could changes in RBC filterability be responsible for some of the pathological consequences of diabetes?
We find it useful here to introduce an objective measure of the capacity of an individual RBC to pass through a small channel. Such a measure is provided by the diameter of the smallest channel through which a given cell can pass without rupture and without causing blockage. We call this measure the "critical diameter." The force offriction between an RBC and the capillary wall must approach infinity as the critical diameter of the cell approaches the capillary diameter. Further, since it requires only one cell to plug a channel, the flow of a heterogeneous suspension of cells will be dominated by those members that offer the greatest resistance. Thus, if other factors are held constant, the flow rate of a suspension of cells through a channel should be approximately proportional to the difference between the maximum critical diameter of the cells and the capillary diameter.
Micromechanical studies have demonstrated that the RBC membrane is very compliant with respect to shear and bending deformations but extremely resistant to changes in surface area (30) . If an RBC of given area and volume is passed through a series of progressively smaller capillaries, there will be a point at which the cell no longer has the reserve membrane area required to enclose the (long, thin) shape it must adopt while squeezing through the passage.
In the Appendix, we present a geometrical derivation that allows one to compute the RBC critical diameter given its surface area and volume. We find that the critical diameter of a normal rat RBC (2.47 ,m) is surprisingly close to the diameter of the smallest capillaries (=3.5 gum). We also show that, to a good approximation, the critical diameter increases in proportion to the ratio of cell volume over surface area. Thus, in accord with our in vitro observations, there is a simple mechanism whereby small amounts of cell swelling are amplified into large changes in filterability.
The critical diameter will increase whenever volume increases or surface area decreases. This in fact is the case in older RBCs, where losses of membrane area in excess of 10% are not uncommon and associated decreases in Nat pump activity may cause concomitant increases in volume. Further, since the channel diameters of our filtration assay are larger than those of the smallest rat capillaries, there is every reason to expect that the effects of cell swelling in vivo will be even larger than what we observe in vitro. We conclude that the cell swelling we have documented is a likely cause of pathology. More experiments to directly test this hypothesis and to precisely delimit the nature, rate of onset, and clinical course ofthe consequences of RBC swelling would be useful.
Of all the chronic complications of diabetes mellitus, the microangiopathy appears most likely to be influenced by RBC swelling and the resulting reduction in microperfusion. Microangiopathy cannot be attributed solely to RBC swelling, however, since extrinsic factors such as plasma viscosity, known to increase in consequence of the increases in fibrinogen concentration (31) , as well as accelerated base-ment membrane thickening (32) and possibly analogous changes in other formed elements including polymorphonuclear leukocytes and platelets, may also contribute to reduced flow. Nevertheless, our data indicate that swollen diabetic RBCs may participate in the evolution of diabetic microangiopathy.
APPENDIX
Consider an RBC of given surface area, A, and volume, V, confined in a channel with diameter equal to the critical diameter, DC. By definition of the critical diameter (see text), the channel must be so narrow as to cause an infinitesimal violation of the constraints of constant surface area and volume. This means that at the critical diameter the configuration of the cell will be such that the cell volume, V, is the largest volume that can possibly be enclosed by the area, A, in a way consistent with the constraints imposed by the channel. In this configuration, the surface of the cell will conform to that of the confining channel over a certain "contact length," Lc. At either end of this cylindrical segment, hemispherical caps will close the cell surface. In other words, at the critical diameter, the cell is forced to take on a "cigar" geometry. The surface area of the cigar geometry is A = 7rDC + 7rDcLc, [1] whereas the volume of the cigar is V = 6 irDc' + 4-fL CD. [2] We now solve Eq. 1 for L, and substitute into Eq. 2. After rearrangements and cancellations we obtain a cubic equation for DC:
-DC -ADc + V = 0.
[3]
12 4 In the rat, V has an average value of66 tum3 and the average value A is -109 um2. The corresponding values in the human are 87 ,tm3 and 143 ,um2 (33) . In either case the nondimentional ratio V2/A3 << 1. We are therefore able to explicitly solve Eq. 3 in terms of a power-series expansion; Dc = (4V/A){1 + (irl6/3)V2/A3 + . . .}. [4] From this expression we calculate that DC for the rat RBC is -2.59 pum (vs. 3.5 pum for the diameter of the smallest capillaries). As a second example, consider what happens if one reduces the surface area by 10% and simultaneously increases cell volume by 10%. In this case, Eq. 4 predicts a critical diameter of 3.27 tum, which is perilously close to the diameter of the smallest capillaries. Eq. 4 also demonstrates that to first order, the expansion is proportional to the ratio of volume to surface (V/A).
The analysis of the critical diameter presented here has incorporated only the most irreducible physical and geometrical constraints of constant volume and surface area. For example, we have neglected the effects of bending and shear elasticity of the membrane. The actual RBC will fail to satisfy this ideal limit, and thus the experimental DC will be even larger than predicted by Eq. 4.
